Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)
Clinical trial NCT05772728 · UNKNOWN
Trial details
- NCT number
- NCT05772728
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2023-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.